COVID-19 Vaccines
Contract number CW2407275
Amendment value : CAD 160,635,561.65
Solicitation number WS5152710602
Contract award date
Expiry date
Amendment date
Amendment type
Amendment
Contract details
This contract was awarded to:
Moderna Biopharma Canada Corporation
- Business address
-
155 Wellington St W Ste 3130Toronto, Ontario, M5V 3H1CA
- Notice type
- Request for Proposal
-
Contract instrument type
-
Contract
- Procurement method
- Competitive – Open Bidding
-
Number of employees
-
49
- Language(s)
-
English,French
- Selection criteria
- Variations or combinations of the above methods
- Region(s) of delivery
-
Canada
Contract duration
The contract will be for a period of 21 month(s), from 2025/06/30 to 2027/03/31.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 360,542,979.65
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canada-Honduras Free Trade Agreement
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Panama Free Trade Agreement
-
Canada-Colombia Free Trade Agreement
-
Canadian Free Trade Agreement (CFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Canada-Chile Free Trade Agreement (CCFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
None
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Marcotte, Karen (SPAC/PSPC)
- Email
- karen.marcotte@tpsgc-pwgsc.gc.ca
Buying organization(s)
Related notices
Amendments made to this contract (1) A total of 1 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
CW2407275 that is awarded to Moderna Biopharma Canada Corporation.
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 000 | CAD 360 542 979.65 | 2025/06/30 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| COVID-19 Vaccines | WS5152710602 | 2025/05/06 | 2025/05/26 |
Contracts awarded (2) This contract has 2 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number WS5152710602. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Pfizer Canada ULC | CW2407284 | 2026/03/31 | 2025/06/30 | Viewthe details of contract CW2407284 for Pfizer Canada ULC |
| Moderna Biopharma Canada Corporation | CW2407275 | 2026/03/31 | 2025/06/30 | Viewthe details of contract CW2407275 for Moderna Biopharma Canada Corporation |
Contract history (3) This contract has 3 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment number
|
Award date
|
More details |
|---|---|---|---|---|
| Pfizer Canada ULC | CW2407284 | 001 | 2025/06/30 | Viewthe details of contract CW2407284 for Pfizer Canada ULC |
| Pfizer Canada ULC | CW2407284 | 000 | 2025/06/30 | Viewthe details of contract CW2407284 for Pfizer Canada ULC |
| Moderna Biopharma Canada Corporation | CW2407275 | 000 | 2025/06/30 | Viewthe details of contract CW2407275 for Moderna Biopharma Canada Corporation |
